Parsons James T. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Parsons James T.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-01+40,739→ 40,739 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (40,739 underlying)
Holdings
- 75,854
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 69,754 shares issuable upon vesting and settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time.
- [F2]Vests in four nearly equal quarterly installments over one year.